PCLAF and glioblastoma: In ST 1 slide, MIA and TransferData analysis demonstrated the unique spatial distribution pattern of C2 PCLAF+ subtype in GBM tissue, suggesting that this subtype might establish specific tumor niches to promote recurrence and drug resistance.